Literature DB >> 16549770

Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes.

Iordanes Karagiannides1, Efi Kokkotou, Morris Tansky, Tamara Tchkonia, Nino Giorgadze, Michael O'Brien, Susan E Leeman, James L Kirkland, Charalabos Pothoulakis.   

Abstract

Intracolonic administration of trinitrobenzene sulfonic acid in mice causes inflammation in the colon that is accompanied by increased expression of proinflammatory cytokines and of the substance P (SP), neurokinin 1 receptor (NK-1R) in the proximal mesenteric fat depot. We also investigated whether human mesenteric preadipocytes contain NK-1R and examined the functional consequences of exposure of these cells to SP as it relates to proinflammatory signaling. We found that human mesenteric preadipocytes express NK-1R both at the mRNA and protein levels. Exposure of human mesenteric preadipocytes to SP increased NK-1R mRNA and protein expression by 3-fold, and stimulated IL-8 mRNA expression and protein secretion. This effect was abolished when these cells were pretreated with the specific NK-1R antagonist CJ 012,255. Moreover, human mesenteric preadipocytes transfected with a luciferase promoter/reporter system containing the IL-8 promoter with a mutated NF-kappaB site lost their ability to respond to SP, indicating that SP-induced IL-8 expression is NF-kappaB-dependent. This report indicates that human mesenteric preadipocytes contain functional SP receptors that are linked to proinflammatory pathways, and that SP can directly increase NK-1R expression. We speculate that mesenteric fat depots may participate in intestinal inflammatory responses via SP-NK-1R-related pathways, as well as other systemic responses to the presence of an ongoing inflammation of the colon.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16549770      PMCID: PMC1458819          DOI: 10.1073/pnas.0600821103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  65 in total

1.  Dynamin and Rab5a-dependent trafficking and signaling of the neurokinin 1 receptor.

Authors:  F Schmidlin; O Dery; K O DeFea; L Slice; S Patierno; C Sternini; E F Grady; N W Bunnett
Journal:  J Biol Chem       Date:  2001-04-16       Impact factor: 5.157

2.  Spinal NK1 receptor is upregulated after chronic bladder irritation.

Authors:  Manabu Ishigooka; Dirk-Henrik Zermann; Ragi Doggweiler; Richard A Schmidt; Tohru Hashimoto; Teruhiro Nakada
Journal:  Pain       Date:  2001-07       Impact factor: 6.961

3.  Interleukin 12 and antigen independently induce substance P receptor expression in T cells in murine schistosomiasis mansoni.

Authors:  A M Blum; A Metwali; C Crawford; J Li; K Qadir; D E Elliott; J V Weinstock
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

4.  Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis.

Authors:  I Castagliuolo; M Riegler; A Pasha; S Nikulasson; B Lu; C Gerard; N P Gerard; C Pothoulakis
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

5.  Epidermal growth factor receptor transactivation mediates substance P-induced mitogenic responses in U-373 MG cells.

Authors:  I Castagliuolo; L Valenick; J Liu; C Pothoulakis
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

6.  The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B.

Authors:  B L Fiebich; S Schleicher; R D Butcher; A Craig; K Lieb
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

Review 7.  Effects of tachykinins on uterine smooth muscle.

Authors:  E N Patak; J N Pennefather; M E Story
Journal:  Clin Exp Pharmacol Physiol       Date:  2000-11       Impact factor: 2.557

8.  Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine.

Authors:  D Renzi; B Pellegrini; F Tonelli; C Surrenti; A Calabrò
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

9.  Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation.

Authors:  T Goode; J O'Connell; P Anton; H Wong; J Reeve; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

10.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase.

Authors:  P M Holland; R D Abramson; R Watson; D H Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

View more
  37 in total

Review 1.  Adipose tissue and inflammatory bowel disease pathogenesis.

Authors:  Christopher Fink; Iordanes Karagiannides; Kyriaki Bakirtzi; Charalabos Pothoulakis
Journal:  Inflamm Bowel Dis       Date:  2012-03-08       Impact factor: 5.325

2.  Role of substance P in the regulation of glucose metabolism via insulin signaling-associated pathways.

Authors:  Iordanes Karagiannides; Kyriaki Bakirtzi; Efi Kokkotou; Dimitris Stavrakis; Kara Gross Margolis; Thomas Thomou; Nino Giorgadze; James L Kirkland; Charalabos Pothoulakis
Journal:  Endocrinology       Date:  2011-10-18       Impact factor: 4.736

Review 3.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

4.  Is obesity a risk factor for Crohn's disease?

Authors:  Michael A Mendall; A Viran Gunasekera; B Joseph John; Devinder Kumar
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

5.  MicroRNA-31-3p Is Involved in Substance P (SP)-Associated Inflammation in Human Colonic Epithelial Cells and Experimental Colitis.

Authors:  Kai Fang; Ivy Ka Man Law; David Padua; Aristea Sideri; Vanessa Huang; Christopher G Kevil; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2017-12-16       Impact factor: 4.307

Review 6.  Neuropeptides, mesenteric fat, and intestinal inflammation.

Authors:  Iordanes Karagiannides; Charalabos Pothoulakis
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

Review 7.  Mechanisms and metabolic implications of regional differences among fat depots.

Authors:  Tamara Tchkonia; Thomas Thomou; Yi Zhu; Iordanes Karagiannides; Charalabos Pothoulakis; Michael D Jensen; James L Kirkland
Journal:  Cell Metab       Date:  2013-04-11       Impact factor: 27.287

8.  Neurotensin induces IL-6 secretion in mouse preadipocytes and adipose tissues during 2,4,6,-trinitrobenzensulphonic acid-induced colitis.

Authors:  Hon-Wai Koon; You Sun Kim; Hua Xu; Aatish Kumar; Dezheng Zhao; Iordanes Karagiannides; Paul R Dobner; Charalabos Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-14       Impact factor: 11.205

Review 9.  Fat tissue, aging, and cellular senescence.

Authors:  Tamara Tchkonia; Dean E Morbeck; Thomas Von Zglinicki; Jan Van Deursen; Joseph Lustgarten; Heidi Scrable; Sundeep Khosla; Michael D Jensen; James L Kirkland
Journal:  Aging Cell       Date:  2010-08-15       Impact factor: 9.304

10.  Substance P promotes expansion of human mesenteric preadipocytes through proliferative and antiapoptotic pathways.

Authors:  Kara Gross; Iordanes Karagiannides; Thomas Thomou; Hon Wai Koon; Collin Bowe; Ho Kim; Nino Giorgadze; Tamara Tchkonia; Tamara Pirtskhalava; James L Kirkland; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-12       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.